National Comprehensive Cancer Network’s new NCCN Guidelines for Patients explain how to recognize and manage immunotherapy-related toxicities, help prepare patients for lengthy treatment duration The National Comprehensive Cancer Network® (NCCN®) today announced the completion of the new NCCN Guidelines for Patients®: Immunotherapy Side Effects series, with the publication of a book focused on chimeric antigen receptor (CAR) T-cell therapy. This …